Drug maker Lupin on Wednesday said its European arm has completed the acquisition of two brands from Sanofi. Lupin Atlantis Holdings SA has completed the acquisition of Aarane in Germany and Nalcrom in Canada and the Netherlands, along with the associated trademark rights, from Sanofi, the Mumbai-based drug maker said in a statement.
The transaction aligns with the company's strategy to grow its global presence in speciality areas, it added.
The acquisition will enhance Lupin's respiratory business in Germany, by aiding in the expansion of the newly established franchise, following the introduction of Luforbec, it said.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
"This acquisition will strengthen our global position in treating patients suffering from diverse respiratory diseases and conditions, and it adds accretive assets in gastro-intestinal care that broaden our portfolio of branded products," Lupin President Corporate Development Fabrice Egros said.
Aarane (sodium cromoglicate/reproterol hydrochloride pressurised inhalation) is a chromone complex indicated in the symptomatic acute treatment of sudden asthma attacks.
Nalcrom (sodium cromoglicate oral) is used to treat food allergies after adequate testing for sensitivity to specific allergens in conjunction with restricting the main allergens.
Shares of Lupin were trading 3.21% higher at Rs 1,613.45 apiece on the BSE.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
